Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tong Ren Tang Technologies CoFRA:TNG -9.71%78 5-Year Yield-on-Cost % is 6.73 as of Aug. 15, 2026, which is 116% above its 10-year median of 3.11. GuruFocus rates FRA:TNG with a GF Score™ of 78/100 and a GF Value™ of €0.52. The stock has 5 warning signs investors should review. Among 511 Drug Manufacturers companies, Tong Ren Tang Technologies Co ranks better than 79.45% on this metric.
The historical rank and industry rank for Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:TNG'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.11 Med: 3.11 Max: 6.56
Current: 6.73
During the past 13 years, Tong Ren Tang Technologies Co's highest Yield on Cost was 6.56. The lowest was 1.11. And the median was 3.11.
FRA:TNG's 5-Year Yield-on-Cost % is ranked better than 79.45% of 511
companies
in the Drug Manufacturers industry
Industry Median: 2.3
vs FRA:TNG: 6.73
Tong Ren Tang Technologies Co (FRA:TNG) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Tong Ren Tang Technologies Co 5-Year Yield-on-Cost % Related Terms
FRA:TNG vs LLY, JNJ, ABBV: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost % falls into.
Tong Ren Tang Technologies Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Tong Ren Tang Technologies Co (FRA:TNG) has a 5-Year Yield-on-Cost % of 6.73 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tong Ren Tang Technologies Co and its competitors. This is 116% above median its historical median of 3.11. Over the past decade, Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost % has ranged from 1.11 to 6.56. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #105 out of 511 companies in the Drug Manufacturers industry, placing it in the top 20.5%.
Is Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost % too high?
Tong Ren Tang Technologies Co's current 5-Year Yield-on-Cost % of 6.73 is 116% above median its 10-year median of 3.11. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 6.56. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.30. Tong Ren Tang Technologies Co's value of 6.73 is 192.6% above this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #105 out of 511 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's 5-Year Yield-on-Cost % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #105 out of 511 companies for 5-Year Yield-on-Cost %. This places Tong Ren Tang Technologies Co in the top 21% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.30. Tong Ren Tang Technologies Co's value of 6.73 is 192.6% above this benchmark. Historically, Tong Ren Tang Technologies Co's own 5-Year Yield-on-Cost % has ranged from 1.11 to 6.56 over the past decade. While the company's 10-year median is 3.11 vs. the industry median of 2.30, Tong Ren Tang Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.30, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current 5-Year Yield-on-Cost % of 6.73 is 192.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current 5-Year Yield-on-Cost % is 6.73, which is 116% above median its own 10-year median of 3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Tong Ren Tang Technologies Co (FRA:TNG) has a current 5-Year Yield-on-Cost % of 6.73. The stock's GF Value™ is €0.52, compared to a current price of €0.32 — trading 39.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 6.73, which is 116% above median its 10-year median of 3.11 and 192.6% above the Drug Manufacturers industry median of 2.30. Tong Ren Tang Technologies Co's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (FRA:TNG), the current 5-Year Yield-on-Cost % is 6.73 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (FRA:TNG) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of €0.32 is trading 39.2% below its estimated GF Value™ of €0.52.
Key valuation signals for FRA:TNG:
5-Year Yield-on-Cost %: 6.73 (116% above median its 10-year median of 3.11)
GF Value™: €0.52 vs. price of €0.32 (39.2% below fair value)
Industry Position: 192.6% above the Drug Manufacturers median (#105 of 511)
No single metric tells the full story. See the FRA:TNG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
78GF Score
Get the complete analysis for FRA:TNG
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TNG has been successfully added to your 
